DIA's 9th Conference on European Electronic Document Management
Drug Information Association (DIA) is conducting an event called 9th Conference on European Electronic Document Management which will be held from 03rd December 2008 in Barcelona, Spain.
Drug Information Association (DIA) is conducting an event called 9th Conference on European Electronic Document Management which will be held from 03rd December 2008 in Barcelona, Spain.
Event Overview:
During the past decades we dreamed, anticipated, waited for a future time when technology would shape a new landscape for EDM. Many of the components have been around for quite a long time. Others are just emerging. But now, for the first time, that future has come to being. EDM in many different shapes, spanning from home-grown systems to hosted repositories, has become the established method for managing official documentation. Registration dossiers are built electronically even for paper submissions and safety information is exchanged in electronic formats. Is this the end of the story? Certainly not but this much is certain: the future we dreamed of then, is now.
Target Audience:
• Document and eRecords Managers
• Standards Implementation Specialists and Associates
• Quality Assurance and Compliance Professionals
• Medical Writers
• IT and Support Personnel
• Contract Researchers and Service Support Providers
• Regulatory Affairs / Operations Professionals
• Academic Researchers
• Regulatory Authority Representatives
• Validation Professionals
• Pharmacovigilance Professionals
• Knowledge / IP Professionals
Can we request you to update the calendar of events on your website to include the details of this event? The details of the event are given below as well as attached. Please let me know if you need any further information.
Event Name
9th Conference on European Electronic Document Management
Event Date
Dec 03 2008 - Dec 05 2008
Event Location
Hilton Barcelona, Barcelona, Spain.
Event Description
During the past decades we dreamed, anticipated, waited for a future time when technology would shape a new landscape for EDM. Many of the components have been around for quite a long time. Others are just emerging. But now, for the first time, that future has come to being. EDM in many different shapes, spanning from home-grown systems to hosted repositories, has become the established method for managing official documentation. Registration dossiers are built electronically even for paper submissions and safety information is exchanged in electronic formats. Is this the end of the story? Certainly not but this much is certain: the future we dreamed of then, is now.
Event Website
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17015&eventType=Meeting
Contact Person
Senior Manager of Marketing
Contact E-Mail ID
talana.bertschi@diaeurope.org
Contact Phone
+41 61 225 51 51
Contact Fax
+41 61 225 51 52
Sponsoring Company Name
Drug Information Association
Company Website
http://www.diahome.org
Company Address
Drug Information Association, European Branch Office, Basel, Switzerland.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
